Navigation Links
Cordex Signs European Development Partnership for ATPotent(TM) Sperm Motility Drug
Date:6/22/2009

Technology Intended to Improve Outcome of Intrauterine Insemination and In Vitro Fertilization Procedures

LA JOLLA, Calif., June 22 /PRNewswire-FirstCall/ -- Cordex Pharma, Inc. (OTC Bulletin Board: CDXP) announced today that it has entered into an agreement with Clinical Trials International, LLC, (CTI), regarding a license to develop and market Cordex's drug candidate, ATPotent(TM).

ATPotent(TM) is a novel ATP-based drug candidate designed for in vitro (outside of the human body) treatment of sperm in conjunction with intrauterine insemination (IUI) and in vitro fertilization (IVF) procedures. ATPotent(TM) is based on Cordex's proprietary technologies related to the use of adenosine 5'-triphosphate (ATP) for improving human and animal sperm motility and fertilization capacity.

According to the agreement, CTI has obtained exclusive rights for the clinical development and marketing of ATPotent(TM) in the European Union (EU) as well as Russia and Ukraine. CTI intends to initiate with Cordex's scientific support a proof-of-concept clinical trial in Italy later this year, the end-point of which is expected to be increased pregnancy rate in IUI procedures prescribed for couples with male infertility due to asthenozoospermia (i.e., low or lack of sperm motility). Cordex will have access to the clinical data to be obtained in this study to support the development of ATPotent(TM) in the rest of the world.

Male factor infertility is implicated in about half of the six million infertile couples in the United States. Lack of, or low sperm motility or movement, is a common cause of human male infertility. It has been reported in the medical literature that the prevalence of asthenozoospermia in infertile men is approximately 82 percent. Currently, there is no FDA-approved drug that enhances sperm motility.

Cordex has sponsored studies at the University of Pennsylvan
'/>"/>

SOURCE Cordex Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Cordex Pharma Announces Strategic Master Services Equity Agreement With Cato BioVentures
2. Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
3. Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis
4. VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
5. Moffitt Cancer Center Signs Licensing Agreement with Frantz BioMarkers, LLC
6. Perceptive Informatics Survey Results Reveal Top Barriers to Implementing Adaptive Trial Designs
7. Optigenex Inc. Signs New License and Distribution Agreement With Itochu Corporation of Japan
8. MultiCell Technologies Signs Liver Stem Cell R&D Agreement To Develop Products for the Study of Liver Cancer
9. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
10. Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey
11. CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... NEW YORK , May 23, 2013  Echo ... has committed to waive down the Acceptance Threshold from ... Affected plus one Elan Share in accordance with the ... to the conditions summarized below. Under the ... to acquire Elan (NYSE: ELN ) for ...
(Date:5/23/2013)... 23, 2013 Nederland keurt als ... urinewegsymptomen geassocieerd met BPH Astellas Pharma ... Astellas Pharma Inc, gebaseerd in Tokyo ... aan dat het Nederlandse College ter Beoordeling van Geneesmiddelen ... De handelsvergunning verleend voor VESOMNI is voor ...
(Date:5/22/2013)... , May 22, 2013 Advanced Prenatal Therapeutics ... device that will help alleviate the high blood pressure ... cartridge is expected to be the first medical device ... maternal and fetal death. Every year, preeclampsia ... United States . It is characterized by high ...
Breaking Medicine Technology:Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 2Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 3Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 4Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2
... , Elsevier,s Pageburst platform to be ... Program Elsevier, the leading global provider of ... today that West Kentucky Community and Technical College ... Technical College System and a public, two-year, degree-granting institution ...
... patent covering tumor suppression technologies, including the company,s lead ... The University of Texas System by the ... discovery that chromosome 3p21.3 genes act as cancer suppressors. ... as FUS1, the anti-cancer agent in Oncoprex ...
Cached Medicine Technology:West Kentucky Community and Technical College Embraces Elsevier's Digital Textbook Platform for Radiography Program 2West Kentucky Community and Technical College Embraces Elsevier's Digital Textbook Platform for Radiography Program 3Genprex Announces New Patent Issuance in Japan 2
(Date:5/23/2013)... (PRWEB) May 23, 2013 According to ... [Converged Services; Policy Management; Subscriber Data Management (SDM); Telecom ... Forecasts and Analysis (2013 – 2018)", published by MarketsandMarkets, ... by 2018 at a CAGR of 9.15% from 2013 ... Market Data Tables , 84 Figures , ...
(Date:5/23/2013)... May 23, 2013 DRE, Inc. is ... as a solution to upgrade older model DRE ... the entire lighting system. , DRE and BFW ... DRE or BFW halogen headlights to LED with DRE’s ... C3 LED Conversion Kit provides a bright, clean and ...
(Date:5/23/2013)... Linda, CA (PRWEB) May 23, 2013 Located ... Fit Body Boot Camp Yorba Linda held its Grand Opening ... goal of spreading awareness about multiple sclerosis and physical fitness. ... premier health and wellness company, the fun filled Grand Opening ... camp prize to show the community what the Yorba ...
(Date:5/23/2013)... Los Angeles,Ca (PRWEB) May 23, 2013 ... with removing every sign associated with Rosacea. This condition ... skin and can affect a person’s self-image. Manufacturers have ... work to help constrict blood vessels near the surface ... and flushing. The new formula is available with special ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 In Florida, residents ... years. This doesn’t mean, however, that Florida’s good luck will ... Center . This year, he encourages residents, it is important ... season 2013, forecasters are predicting there to be a 50-percent ... WUFT . With hurricane season lasting from June 1 to ...
Breaking Medicine News(10 mins):Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 2Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 3Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 2Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 3Health News:Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event 2Health News:Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event 3Health News:Revitol Rosacea Now Comes with Anti-Inflammatory Ingredients to Remove Redness and Flushing 2Health News:As Hurricane Season Nears, Skylake Insurance Encourages Florida Residents To Prepare Early For Safety 2
... Common Shares Issued and Listed on OTCBB, ... (OTC Bullets and Board: CHHB) (,China,Bio-Immunity" or "the ... share exchange agreement with Lawford Asia Limited (,Lawford,).,According ... all of the issued and outstanding stock of ...
... Grant Stevens, MERRIMACK, N.H., Aug. 6 ... Medical Inc. announced today that Grant,Stevens, MD, will ... to offer,the SmoothShapes(R) system for longer lasting cellulite ... dynamic light therapy, in addition,to contoured rollers and ...
... eDiets.com,Inc. (Nasdaq: DIET ), leveraging the power of ... to everyone, today announced,results for the second quarter and ... the second quarter of 2008 were $6.5 million, compared ... for the quarter was $(3.1),million, or $(0.12) per diluted ...
... Raritan, NJ, August 6, 2008 The nation,s first, ... (cSSTIs), known as SSTIR (the Skin and Soft Tissue ... plans to enroll more than 1,200 hospitalized patients by ... better understand treatment patterns and provide data to help ...
... study finds , , WEDNESDAY, Aug. 6 (HealthDay News) -- Stroke ... times as likely to die in the hospital or be ... new Canadian study suggests. , The finding is based ... recovery from an ischemic stroke. Ischemic strokes are the most ...
... than to adults. That,s one reason why abstinence-only ... sexual activity, according to new University of Washington research., , ... treated abstinence and sexual activity as opposites. However, teenagers ... Tatiana Masters, lead author of a new study and ...
Cached Medicine News:Health News:China Bio-Immunity Corporation Completes Share Exchange and Reverse Merger 2Health News:China Bio-Immunity Corporation Completes Share Exchange and Reverse Merger 3Health News:China Bio-Immunity Corporation Completes Share Exchange and Reverse Merger 4Health News:New Anti-Cellulite Treatment Prepares Women for Fall's Short Skirts 2Health News:New Anti-Cellulite Treatment Prepares Women for Fall's Short Skirts 3Health News:eDiets.com(R) Announces Q2 2008 Results 2Health News:eDiets.com(R) Announces Q2 2008 Results 3Health News:eDiets.com(R) Announces Q2 2008 Results 4Health News:eDiets.com(R) Announces Q2 2008 Results 5Health News:eDiets.com(R) Announces Q2 2008 Results 6Health News:eDiets.com(R) Announces Q2 2008 Results 7Health News:Ortho-McNeil initiates first-of-its-kind skin infection registry 2Health News:GI Bleeding After Stroke Raises Death Risk 2Health News:GI Bleeding After Stroke Raises Death Risk 3Health News:When it comes to abstinence teens, adults aren't speaking the same language 2Health News:When it comes to abstinence teens, adults aren't speaking the same language 3
Bartels Clostridium difficile Toxin A Enzyme Immunoassay (EIA) is intended for the qualitative detection of Clostridium difficile Toxin A in human faecal specimens as an aid in the diagnosis of Clost...
One step Immuno-Chromatographic Assay for the detection of C. difficile toxin A....
... CCD cameras provide fast, accurate, reliable and ... quality at an excellent price. , , ... TOMEY TR-4000 Auto Refractor provides highly accurate ... is obtained simply by pushing a button. ...
... Rechargeable, cordless slit-lamp microscope Portable, for ... Easy selection of slit width , ... halogen lamp light source , Simultaneous ... pack , Supports digital / video ...
Medicine Products: